About Hannah Harris Green

I'm an investigative data journalist and epidemiology student. Here's my BlueSky.

• My favorite topic is mind-altering drugs—the science behind how they work, which ones end up legal, which ones end up stigmatized, and how they change people's lives. I began reporting on this topic when I embedded with an underground Harm Reduction group in West Virginia in 2021.

• Subscribe to What's it like? my forthcoming newsletter on the science and experience of drugs. Topics will include what it's like to have an overdose reversed with naloxone, everything we know about kratom, and what happens when you mix weed with prescription drugs.

•You can read most of my recent work over at The Guardian, where I contribute frequent news and investigative stories.

• In 2025, I've also focused my reporting on how private equity companies are hurting patients. My investigative series on private equity backed prison health companies scrutinized how they tried to use the bankruptcy system to escape liability for a decade of constitutional violations.

•This year, I was a co-author on a scientific study about the orgasm gap published in Psychology and Sexuality. The study used data from a survey I designed for an episode of Science Vs. podcast. That episode, which I also lead produced, won the audience vote for Favorite Sex Episode.

•My 2019 reporting on how medical schools used unconscious patients as practice tools for pelvic exams without consent was used to support legislation banning this practice in some states, which was forbidden nationally in 2024.

•I will graduate with my MS in Epidemiology from Northwestern in 2027.

•My work has received recognition and financial support from Fulbright, Tribeca, Third Coast, New York Festivals, The Pulitzer Center for Crisis Reporting, the Investigative Fund, and USC's Impact Fund.